SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Heart. 2020;106(15):1160-1168.

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.

, , , ,

제1저자 손미경, 박진주 · 교신저자 김원호, 최동주

소속 (4)
  1. Division of Cardiovascular Diseases, Korea National Institute of Health, Cheongju, Chungcheongbuk-do, The Republic of Korea.
  2. Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, The Republic of Korea.
  3. Division of Cardiovascular Diseases, Korea National Institute of Health, Cheongju, Chungcheongbuk-do, The Republic of Korea jhkwh@nih.go.kr djchoi@snubh.org.
  4. Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi, The Republic of Korea jhkwh@nih.go.kr djchoi@snubh.org.

Abstract

OBJECTIVE To determine the prognostic value of atrial fibrillation (AF) in patients with heart failure (HF) and preserved, mid-range or reduced ejection fraction (EF).

METHODS Patients hospitalised for acute HF were enrolled in the Korean Acute Heart Failure registry, a prospective, observational, multicentre cohort study, between March 2011 and February 2014. HF types were defined as reduced EF (HFrEF, LVEF <40%), mid-range EF (HFmrEF, LVEF 40%-49%) or preserved EF (HFpEF, LVEF ≥50%).

RESULTS Of 5414 patients enrolled, HFrEF, HFmrEF and HFpEF were seen in 3182 (58.8%), 875 (16.2%) and 1357 (25.1%) patients, respectively. The prevalence of AF significantly increased with increasing EF (HFrEF 28.9%, HFmrEF 39.8%, HFpEF 45.2%; p for trend <0.001). During follow-up (median, 4.03 years; IQR, 1.39-5.58 years), 2806 (51.8%) patients died. The adjusted HR of AF for all-cause death was 1.06 (0.93-1.21) in the HFrEF, 1.10 (0.87-1.39) in the HFmrEF and 1.22 (1.02-1.46) in the HFpEF groups. The HR for the composite of all-cause death or readmission was 0.97 (0.87-1.07), 1.14 (0.93-1.38) and 1.03 (0.88-1.19) in the HFrEF, HFmrEF and HFpEF groups, respectively, and the HR for stroke was 1.53 (1.03-2.29), 1.04 (0.57-1.91) and 1.90 (1.13-3.20), respectively. Similar results were observed after propensity score matching analysis.

CONCLUSIONS AF was more common with increasing EF. AF was seen to be associated with increased mortality only in patients with HFpEF and was associated with an increased risk of stroke in patients with HFrEF or HFpEF.

TRIAL REGISTRATION NUMBER NCT01389843.

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Keywords

atrial fibrillationepidemiologyheart failure with preserved ejection fractionheart failure with reduced ejection fractionstroke

Figures

Figure 1
Figure 1 Study population flow chart. HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LVEF, left ventricular ejection fraction.
Figure 2
Figure 2 Prevalence of AF in patients with HFrEF, HFmrEF and HFpEF according to age and sex; p value for trend. AF, atrial fibrillation; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
Figure 3
Figure 3 Kaplan-Meier curves for unmatched cohort. Data are stratified by the three ejection fraction groups and the presence or absence of AF for (A) all-cause mortality, (B) all-cause mortality or rehospitalisation, (C) CVD mortality and (D) stroke. AF, atrial fibrillation; CVD, cardiovascular disease; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
Figure 4
Figure 4 Multivariable HR for adverse outcomes associated with AF, according to EF groups: A. unmatched cohort and B. propensity score matched cohort. AF, atrial fibrillation; CVD, cardiovascular disease; EF, ejection fraction; HFmrEF, heart failure with mid-range ejection fraction; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.

그림 출처: PubMed Central 공개 논문 (PMC7398483)

Comment · 정정

Conflict of interest statement

Competing interests: None declared.

그 밖의 정보
출판 형태
Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't
저널
Heart (British Cardiac Society) · eISSN 1468-201X
전자 출판
2020-04-27
MeSH
Aged · Aged, 80 and over · Atrial Fibrillation / diagnosis / mortality / physiopathology / therapy · Cause of Death · Female · Heart Failure / diagnosis / mortality / physiopathology / therapy · Heart Rate* · Humans · Male · Middle Aged · Patient Readmission · Prevalence · Prognosis · Prospective Studies · Registries · Republic of Korea / epidemiology · Risk Assessment · Risk Factors · Stroke / diagnosis / mortality / physiopathology / therapy · Stroke Volume* · Time Factors · Ventricular Function, Left*
데이터
ClinicalTrials.gov: NCT01389843
참고문헌
29편